These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 29219207)
1. Motor complications in Parkinson's disease: Striatal molecular and electrophysiological mechanisms of dyskinesias. Picconi B; Hernández LF; Obeso JA; Calabresi P Mov Disord; 2018 Jul; 33(6):867-876. PubMed ID: 29219207 [TBL] [Abstract][Full Text] [Related]
2. [Development of dyskinesias induced by treatment for Parkinson's disease: potential role of first exposure to L-DOPA (or phenomenon of priming)]. Damier P; Tremblay L; Féger J; Hirsch EC Rev Neurol (Paris); 2000 Mar; 156(3):224-35. PubMed ID: 10740093 [TBL] [Abstract][Full Text] [Related]
3. Eltoprazine prevents levodopa-induced dyskinesias by reducing striatal glutamate and direct pathway activity. Paolone G; Brugnoli A; Arcuri L; Mercatelli D; Morari M Mov Disord; 2015 Nov; 30(13):1728-38. PubMed ID: 26207892 [TBL] [Abstract][Full Text] [Related]
4. l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiation. Picconi B; Paillé V; Ghiglieri V; Bagetta V; Barone I; Lindgren HS; Bernardi G; Angela Cenci M; Calabresi P Neurobiol Dis; 2008 Feb; 29(2):327-35. PubMed ID: 17997101 [TBL] [Abstract][Full Text] [Related]
5. Striatal activation by optogenetics induces dyskinesias in the 6-hydroxydopamine rat model of Parkinson disease. F Hernández L; Castela I; Ruiz-DeDiego I; Obeso JA; Moratalla R Mov Disord; 2017 Apr; 32(4):530-537. PubMed ID: 28256089 [TBL] [Abstract][Full Text] [Related]
6. Striatal tyrosine hydroxylase-positive neurons are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice. Keber U; Klietz M; Carlsson T; Oertel WH; Weihe E; Schäfer MK; Höglinger GU; Depboylu C Neuroscience; 2015 Jul; 298():302-17. PubMed ID: 25892702 [TBL] [Abstract][Full Text] [Related]
7. Neurobiology of l-DOPA induced dyskinesia and the novel therapeutic strategies. Sharma S; Singh S; Sharma V; Singh VP; Deshmukh R Biomed Pharmacother; 2015 Mar; 70():283-93. PubMed ID: 25776513 [TBL] [Abstract][Full Text] [Related]
8. Implanted reuptake-deficient or wild-type dopaminergic neurons improve ON L-dopa dyskinesias without OFF-dyskinesias in a rat model of Parkinson's disease. Vinuela A; Hallett PJ; Reske-Nielsen C; Patterson M; Sotnikova TD; Caron MG; Gainetdinov RR; Isacson O Brain; 2008 Dec; 131(Pt 12):3361-79. PubMed ID: 18988638 [TBL] [Abstract][Full Text] [Related]
11. Effect of non-dopaminergic drug treatment on Levodopa induced dyskinesias in MPTP monkeys: common implication of striatal neuropeptides. Tamim MK; Samadi P; Morissette M; Grégoire L; Ouattara B; Lévesque D; Rouillard C; Di Paolo T Neuropharmacology; 2010 Jan; 58(1):286-96. PubMed ID: 19576910 [TBL] [Abstract][Full Text] [Related]
12. Striatal Akt/GSK3 signaling pathway in the development of L-Dopa-induced dyskinesias in MPTP monkeys. Morissette M; Samadi P; Hadj Tahar A; Bélanger N; Di Paolo T Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):446-54. PubMed ID: 20026151 [TBL] [Abstract][Full Text] [Related]